Peter Maag - Chief Executive Officer, Director at Kyverna Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
KYTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Peter Maag since 26 Aug 2025

Reported holdings for Peter Maag in Kyverna Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
349,321
Estimated value
Report date
07 Feb 2024
Price
Ownership
By The Maag Family Irrevocable Trust
Form 4 holding Chief Executive Officer, Director

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
58,220
Estimated value
Report date
07 Feb 2024
Price
Ownership
Direct

Transaction history for Peter Maag in Kyverna Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .